Becton Dickinson Settles SEC Investigation with $175 Million Payout

Becton Dickinson and Company, a prominent medical technology firm, has agreed to settle a significant investigation by the U.S. Securities and Exchange Commission (SEC) by paying $175 million. This decision comes as the company faced scrutiny regarding its financial reporting practices and alleged violations of federal securities laws.

Continue reading